Authors: Wazny, LD Daghigh, B

Citation: Ld. Wazny et B. Daghigh, Desensitization protocols for vancomycin hypersensitivity, ANN PHARMAC, 35(11), 2001, pp. 1458-1464

Authors: Brophy, DF Wazny, LD Gehr, TWB Comstock, TJ Venitz, J

Citation: Df. Brophy et al., Low-molecular-weight heparin administration in patients with end-stage renal disease - Author's reply, PHARMACOTHE, 21(8), 2001, pp. 1017-1019

Authors: Brophy, DF Wazny, LD Gehr, TWB Comstock, TJ Venitz, J

Citation: Df. Brophy et al., The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease, PHARMACOTHE, 21(2), 2001, pp. 169-174

Authors: Wazny, LD Brophy, DF

Citation: Ld. Wazny et Df. Brophy, Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia, ANN PHARMAC, 34(1), 2000, pp. 94-97

Authors: Wazny, LD Ariano, RE

Citation: Ld. Wazny et Re. Ariano, Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient, PHARMACOTHE, 20(3), 2000, pp. 292-307

Authors: Brophy, DF Crouch, MA Ruffin, DM Wazny, LD McKenney, JM

Citation: Df. Brophy et al., Pharmacotherapy of dyslipidemia in postmenopausal women: Weighing the evidence, J WOMEN H G, 8(7), 1999, pp. 901-917